Back
West Pharmaceutical Services, I (WST)
Life Sciences Tools & ServicesWST · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$353.68
−0.67%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$6.79
ROE
19.1%
Gross margin
36.3%
Debt/Equity
0.11x
Revenue growth
21.0%
West Pharmaceutical Services, I — company intelligence
Earnings surprises
Q1 2026$2.13 vs $1.69 est+25.8%
Q4 2025$2.04 vs $1.85 est+10.2%
Q3 2025$1.96 vs $1.70 est+15.4%
Q2 2025$1.84 vs $1.52 est+20.7%
Analyst consensus · 22 analysts
18 Buy4 Hold0 Sell
Updated Jul 6, 2026
Insider activity · 90 days
11 buys2 sellsnet +7,737 shares
HAUGEN JANET BRUTSCHEABuy 46 · Jun 30, 2026
Campbell Shane AldenSell 84 · May 12, 2026
Campbell Shane AldenSell 135 · May 12, 2026
Recent SEC filings
4 — Insider transaction reportJul 1, 2026
8-K — Material event reportJun 1, 2026
4 — Insider transaction reportMay 14, 2026
Latest news
TransMedics Completes PAD Aviation Investment to Expand in Europe — Yahoo · 3d ago
Here's Why You Should Add PacBio Stock to Your Portfolio Now — Yahoo · 3d ago
CareDx Completes Naveris Acquisition and Expands Oncology Reach — Yahoo · 3d ago
Here's Why You Should Retain AMN Stock in Your Portfolio for Now — Yahoo · 3d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About West Pharmaceutical Services, I
Weekly undervalued picks (like WST)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.